Efficacy News and Research

RSS
Researchers temporarily turn off essential gene using RNAi technology

Researchers temporarily turn off essential gene using RNAi technology

QRxPharma receives new U.S. Patent for MoxDuo IR in treatment of acute pain

QRxPharma receives new U.S. Patent for MoxDuo IR in treatment of acute pain

NRC, NCKU partner to develop cancer diagnostic and treatment technologies

NRC, NCKU partner to develop cancer diagnostic and treatment technologies

The Wistar Institute, Advaxis enter research collaboration

The Wistar Institute, Advaxis enter research collaboration

Cerapedics announces i-FACTOR biologic bone graft study results in PLIF spine surgery

Cerapedics announces i-FACTOR biologic bone graft study results in PLIF spine surgery

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Positive results from ULCA's Phase 1 dendritic cell vaccine trial in glioblastoma

Positive results from ULCA's Phase 1 dendritic cell vaccine trial in glioblastoma

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Positive results from laquinimod Phase III ALLEGRO study in multiple sclerosis to be presented at AAN

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Positive interim results from PROLOR's hGH-CTP Phase II trial in growth hormone deficiency

Positive interim results from PROLOR's hGH-CTP Phase II trial in growth hormone deficiency

Positive top-line results from Biogen BG-12 Phase 3 trial in RRMS

Positive top-line results from Biogen BG-12 Phase 3 trial in RRMS

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

Blood journal to publish Soliris study results in Paroxysmal Nocturnal Haemoglobinuria

Blood journal to publish Soliris study results in Paroxysmal Nocturnal Haemoglobinuria

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

Annals of Neurology publishes Diamyd Medical´s NP2 Enkephalin Phase I results in cancer pain

New point-of-care trial can reduce cost and length of studies

New point-of-care trial can reduce cost and length of studies

Gilenya can reduce risk of disability progression in patients with RRMS

Gilenya can reduce risk of disability progression in patients with RRMS

Louisville Chief of Cardiovascular Medicine earns APS' Walter B. Cannon Award

Louisville Chief of Cardiovascular Medicine earns APS' Walter B. Cannon Award

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

Elekta to highlight Leksell Gamma Knife Perfexion radiosurgery solution at AANS 2011

Current 'metrics' don't paint clear picture of health care quality

Current 'metrics' don't paint clear picture of health care quality

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.